To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.
X

Privacy Policy Update

We remain dedicated to protecting your data and experience throughout our platforms. We have updated our Privacy Policy and your continued use of the Site means you have accepted the revised Privacy Policy. View now >
X
Search

Genomic RNA from Severe acute respiratory syndrome-related coronavirus 2 (ATCC® VR-1994D™)

Genome Data Seal Click here to learn about our Enhanced Authentication Initiative

Product Format: frozen 100 µL per vial

Agent Genomic RNA from Severe acute respiratory syndrome-related coronavirus 2
Strain Germany/BavPat1/2020
Verified By Whole-genome Sequencing
Applications ATCC® Genuine Nucleics can be used for assay development, verification, validation, monitoring of day-to-day test variation, and lot-to-lot performance of molecular-based assays. The quantitative format allows for the generation of a standard curve for quantitative PCR (qPCR) to determine viral load.
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format frozen 100 µL per vial
Storage Conditions -70°C or colder
Comments

Due to high demand, this product is limited to 20 per organization.

Genomic RNA isolated from a preparation of Severe acute respiratory syndrome-related coronavirus 2 strain Germany/BavPat1/2020.

Genomic RNA from SARS-CoV-2 must be handled at BSL-2 containment.

Whole-genome sequencing has shown the presence of the D614G mutation in this isolate.

Acknowledgment for publications should read "The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: Genomic RNA from SARS-Related Coronavirus 2, Isolate Germany/BavPat1/2020, NR-52502."
Name of Depositor CDC
References

Zhang L, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv doi: 10.1101/202006.12.148726, 2020. PubMed: 32587973